Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES
about
Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTESOligomeric Structure of the Chemokine CCL5/RANTES from NMR, MS, and SAXS DataTotal chemical synthesis and electrophysiological characterization of mechanosensitive channels from Escherichia coli and Mycobacterium tuberculosisAcceleration of thiol additive-free native chemical ligation by intramolecular S → S acyl transfer.Peptide and protein-based inhibitors of HIV-1 co-receptorsHuman immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.His6 tag-assisted chemical protein synthesisChallenges for protein chemical synthesis in the 21st century: bridging genomics and proteomics.Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity.Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTESPSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells.Homology modeling and molecular dynamics simulations of lymphotactin.Design, total chemical synthesis, and binding properties of a [Leu-91-N1-methyl-7-azaTrp]Ras-binding domain of c-Raf-1.A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.Rational design of novel HIV-1 entry inhibitors by RANTES engineeringStructural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors.Traceless purification and desulfurization of tau protein ligation products.RP105 involved in activation of mouse macrophages via TLR2 and TLR4 signaling.
P2860
Q27657257-5FFB9409-DC7C-425A-A9F0-B10A6418017DQ27671636-92B0E60A-583C-4B1A-99C5-4DA297CC4780Q28252515-06C100AD-36D9-4D54-B225-248353CAFFD1Q30009195-9194B48A-6596-4C54-9055-60C8A812B558Q30352117-D713DCFF-2F85-4F08-AB2A-4468FB226EA7Q30938337-081FD7D2-4964-4925-AB76-E1A85C089A28Q33835337-E56F1877-F142-4737-A9CB-498BA0BAC5F1Q33935814-86892614-453B-41BB-9428-EFB3FEA87C82Q34080662-BFAE11C5-E703-49ED-B210-6E8165150004Q34510719-C36D83F5-D590-4429-8B7F-779E14A86401Q34682512-3C1D0A35-F281-4FBB-9385-04AD3FBA7935Q34768558-8526C0C3-BB9B-43E4-BD6D-8C2BED940CEFQ34823587-69226BA3-C260-4937-B719-6E354C5F17F3Q35122309-DB4FFE49-E671-4650-8F73-37155BAE0CFEQ36028163-A13DE0CF-2235-45DA-876C-A9E0CAF67E3FQ36281781-2425518C-5F8B-4802-BEC0-5E5501CC3606Q36408188-7E8E4AD4-FCC7-4F5B-921F-45441E8944B7Q36498554-241DE1ED-2633-4E4E-94D2-EDAE4C92BB21Q36793736-09C40C09-9EDE-4A71-97EC-D22F6AA8FC05Q37173170-76F9ACF5-EB09-40CC-90C8-6B32B75B1F9BQ37692401-B418FFCC-CC22-4F8E-A46D-557FF2C6BA4EQ51034701-FABE88FC-D46B-48AB-B5A2-53447605F337Q54444645-B0DB2083-29F5-4DCC-BDDE-8F8E1F231A11
P2860
Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@ast
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@en
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@nl
type
label
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@ast
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@en
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@nl
prefLabel
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@ast
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@en
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@nl
P2093
P1476
Total chemical synthesis and h ...... nt anti-HIV protein AOP-RANTES
@en
P2093
A Wlodawer
D A Thompson
H McSparron
J Lubkowski
P N Barlow
P356
10.1016/S1074-5521(99)80019-2
P577
1999-01-01T00:00:00Z